Relation of body mass index to cancer risk in 362,552 Swedish men
- 837 Downloads
Obesity has been linked with increased risk for cancers of the colon, kidney, breast, endometrium and gallbladder. For other cancer sites, the relationship with obesity is less well quantified, and the effect of weight change on cancer risk is unclear.
We examined the health records of 362,552 Swedish men who underwent at least one physical examination from 1971 to 1992, and were followed until death or the end of 1999. Incident cancer cases were identified by linkage to the Swedish cancer registry. Poisson regression models were used to estimate relative risks of cancer for both body-mass index (BMI) at baseline exam and, in a subgroup of 107,815 men, change in BMI after six years of follow-up, adjusting for age and smoking status.
Compared to men of normal weight, obese men had a significantly increased risk of all cancers combined (RR = 1.1; 95% CI = 1.0–1.2). The risks were most pronounced for esophageal adenocarcinoma (RR = 2.7; 95% CI = 1.3–5.6), renal cell carcinoma (RR = 1.8; 95% CI = 1.4–2.4), malignant melanoma (RR = 1.4; 95% CI = 1.1–1.7), and cancers of the colon (RR = 1.7; 95% CI = 1.5–2.0), rectum (RR = 1.4; 95% CI = 1.1–1.7), and liver (RR = 3.6; 95% CI = 2.6–5.0). Risk of esophageal squamous cell carcinoma was elevated for underweight men whose BMI was less than 18.5 (RR = 3.1; 95% CI = 1.1–8.3). An excess risk for cancers of the pancreas and connective tissue was observed only among nonsmokers. Compared to men whose weight remained stable, men with more than a 15% increase in BMI after six years of follow-up had an elevated risk of pancreas and renal cell cancers.
Obesity and weight gain increase the risk for several forms of cancer in men, and underscore the need for further study into carcinogenic mechanisms and preventive interventions.
KeywordsObesity Cancer incidence Body mass index Sweden
- 1.IARC handbooks of cancer prevention (2002) Weight control and physical activity, vol 6. International Agency for Research on Cancer, Lyon, FranceGoogle Scholar
- 12.Report of a WHO consultation. Obesity: preventing, managing the global epidemic. 894:i–xii, 1–253. 2000. World Health Organization. World Health Organ Tech Rep SerGoogle Scholar
- 14.Preston DL, Lubin JH, Pierce DA, McConney ME (1996) Epicure User's Guide. HiroSoft International Corporation, Seattle, WAGoogle Scholar
- 15.Breslow NE, Day NE (1987) The design and analysis of cohort studies. In: International Agency for Research on Cancer, ed. In: Statistical methods in cancer research. LyonGoogle Scholar
- 18.Lagergren J, Bergstrom R, Nyren O (1999) Association between body mass index and adenocarcinoma of the esophagus and gastric cardia. Arch Intern Med 130:883–890Google Scholar
- 25.Vaughan TL, Davis S, Kristal A, Thomas DB (1995) Obesity, alcohol and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma. Cancer Epidem Biomarkers Prev 4:85–92Google Scholar
- 44.Nomura AM (2001) Body size and prostate cancer risk. Epidemiol Rev 126–131Google Scholar
- 48.Giovanucci E, Rimm EB, Stampfer MJ, Colditz GA, Willett WC (1997) Height, body weight and risk of prostate cancer. Cancer Epidem Biomarkers Prev 6:557–563Google Scholar
- 64.Gallus S, Naldi L, Martin L, Martinelli M, Carlo La Vecchia on behalf of the Oncology Study Group of the Italian Group for Epidemiologic Research in Dermatology (GISED) (2006) Anthropometric measures and risk of cutaneous malignant melanoma: a case–control study from Italy. Melanoma Res 16:83–87PubMedCrossRefGoogle Scholar
- 76.Armstrong BK, Englund A (1996) Cutaneous malignant melanoma. In: Schottenfield D, Fraumeni JF Jr. (eds) New York, NY: Oxford University Press, pp 1282–1312Google Scholar
- 86.Oliveria SA, Christos PJ (1997) The epidemiology of physical activity and cancer. Ann NY Acad Sci 29:79–90Google Scholar
- 89.La Vecchia C (1994) Dietary fat, obesity and cancer. In: Hill M, Giacosa A, Caygill C (eds) Epidemiology of diet and cancer. Ellis Horwood Limited, New York, pp 277–291Google Scholar
- 94.Marchav S (1998) The haematopoietic effects of growth hormone and insulin-like growth factor-I. J Ped Endocrinol Metab 11:677–685Google Scholar